vs
Side-by-side financial comparison of ASTROTECH Corp (ASTC) and Cardiff Oncology, Inc. (CRDF). Click either name above to swap in a different company.
Cardiff Oncology, Inc. is the larger business by last-quarter revenue ($243.0K vs $148.0K, roughly 1.6× ASTROTECH Corp). ASTROTECH Corp runs the higher net margin — -2653.4% vs -2969.5%, a 316.2% gap on every dollar of revenue. On growth, Cardiff Oncology, Inc. posted the faster year-over-year revenue change (62.0% vs -43.3%). Over the past eight quarters, Cardiff Oncology, Inc.'s revenue compounded faster (8.9% CAGR vs -40.2%).
Astrotech Corporation, formerly Spacehab Inc., is a technology incubator headquartered in Austin, Texas. Astrotech uses technology sourced internally and from research institutions, government laboratories, and universities to fund, manage and sell start-up companies. Astrotech Corporation's subsidiaries provide commercial products and services to NASA, the U.S. Department of Defense, national space agencies, and global commercial customers.
ASTC vs CRDF — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $148.0K | $243.0K |
| Net Profit | $-3.9M | $-7.2M |
| Gross Margin | 5.4% | — |
| Operating Margin | -2635.8% | -3221.0% |
| Net Margin | -2653.4% | -2969.5% |
| Revenue YoY | -43.3% | 62.0% |
| Net Profit YoY | 2.0% | 38.8% |
| EPS (diluted) | — | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $148.0K | $243.0K | ||
| Q3 25 | $297.0K | $120.0K | ||
| Q2 25 | $220.0K | $121.0K | ||
| Q1 25 | $534.0K | $109.0K | ||
| Q4 24 | $261.0K | $150.0K | ||
| Q3 24 | — | $165.0K | ||
| Q2 24 | — | $163.0K | ||
| Q1 24 | — | $205.0K |
| Q4 25 | $-3.9M | $-7.2M | ||
| Q3 25 | $-3.5M | $-11.3M | ||
| Q2 25 | $-2.9M | $-13.9M | ||
| Q1 25 | $-3.6M | $-13.4M | ||
| Q4 24 | $-4.0M | $-11.8M | ||
| Q3 24 | — | $-11.9M | ||
| Q2 24 | — | $-11.8M | ||
| Q1 24 | — | $-10.0M |
| Q4 25 | 5.4% | — | ||
| Q3 25 | 63.3% | — | ||
| Q2 25 | 33.6% | — | ||
| Q1 25 | 44.4% | — | ||
| Q4 24 | 59.4% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -2635.8% | -3221.0% | ||
| Q3 25 | -1190.6% | -9978.3% | ||
| Q2 25 | -1326.4% | -12212.4% | ||
| Q1 25 | -724.2% | -13194.5% | ||
| Q4 24 | -1655.6% | -8381.3% | ||
| Q3 24 | — | -7637.0% | ||
| Q2 24 | — | -7696.3% | ||
| Q1 24 | — | -5333.2% |
| Q4 25 | -2653.4% | -2969.5% | ||
| Q3 25 | -1166.7% | -9381.7% | ||
| Q2 25 | -1331.8% | -11523.1% | ||
| Q1 25 | -680.3% | -12324.8% | ||
| Q4 24 | -1536.0% | -7858.0% | ||
| Q3 24 | — | -7184.8% | ||
| Q2 24 | — | -7225.8% | ||
| Q1 24 | — | -4883.4% |
| Q4 25 | — | $-0.11 | ||
| Q3 25 | — | $-0.17 | ||
| Q2 25 | — | $-0.21 | ||
| Q1 25 | — | $-0.20 | ||
| Q4 24 | — | $-0.22 | ||
| Q3 24 | — | $-0.25 | ||
| Q2 24 | — | $-0.26 | ||
| Q1 24 | — | $-0.22 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.0M | $58.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $15.5M | $45.4M |
| Total Assets | $19.7M | $61.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.0M | $58.3M | ||
| Q3 25 | $11.3M | $60.6M | ||
| Q2 25 | $15.1M | $71.0M | ||
| Q1 25 | $18.1M | $79.9M | ||
| Q4 24 | $21.5M | $91.7M | ||
| Q3 24 | — | $57.7M | ||
| Q2 24 | — | $60.3M | ||
| Q1 24 | — | $67.2M |
| Q4 25 | $15.5M | $45.4M | ||
| Q3 25 | $19.1M | $48.8M | ||
| Q2 25 | $22.1M | $58.6M | ||
| Q1 25 | $24.8M | $70.9M | ||
| Q4 24 | $28.1M | $82.9M | ||
| Q3 24 | — | $49.4M | ||
| Q2 24 | — | $52.4M | ||
| Q1 24 | — | $60.9M |
| Q4 25 | $19.7M | $61.9M | ||
| Q3 25 | $23.2M | $63.8M | ||
| Q2 25 | $27.0M | $75.7M | ||
| Q1 25 | $27.5M | $84.8M | ||
| Q4 24 | $31.0M | $97.2M | ||
| Q3 24 | — | $62.9M | ||
| Q2 24 | — | $66.1M | ||
| Q1 24 | — | $74.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.5M | $-6.0M |
| Free Cash FlowOCF − Capex | $-4.0M | — |
| FCF MarginFCF / Revenue | -2671.6% | — |
| Capex IntensityCapex / Revenue | 277.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-14.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-3.5M | $-6.0M | ||
| Q3 25 | $-3.9M | $-10.8M | ||
| Q2 25 | $-2.4M | $-8.3M | ||
| Q1 25 | $-3.9M | $-12.8M | ||
| Q4 24 | $-3.0M | $-10.3M | ||
| Q3 24 | — | $-10.5M | ||
| Q2 24 | — | $-9.2M | ||
| Q1 24 | — | $-7.7M |
| Q4 25 | $-4.0M | — | ||
| Q3 25 | $-4.4M | $-10.9M | ||
| Q2 25 | $-2.7M | — | ||
| Q1 25 | $-3.9M | — | ||
| Q4 24 | $-3.4M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-7.8M |
| Q4 25 | -2671.6% | — | ||
| Q3 25 | -1476.1% | -9043.3% | ||
| Q2 25 | -1231.4% | — | ||
| Q1 25 | -728.1% | — | ||
| Q4 24 | -1288.5% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -3814.6% |
| Q4 25 | 277.7% | — | ||
| Q3 25 | 150.8% | 15.0% | ||
| Q2 25 | 158.2% | — | ||
| Q1 25 | 5.1% | — | ||
| Q4 24 | 122.2% | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 39.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
